Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2015 / Jan / Benchmarking PSA
Oncology Oncology Hematology Digital and computational pathology Bioinformatics Technology and innovation Research and Innovations

Benchmarking PSA

What does analysis of the last five years of literature on prostate specific antigen tell us about the priorities of the field and the major contributors to it?

By Mark Hillen 01/27/2015 1 min read

Share

Prostate-specific antigen (PSA) is a glycoprotein enzyme secreted by the epithelial cells of the prostate gland. Its main role is to liquefy semen in the seminal coagulum, thus allowing sperm to swim freely. Small amounts are also present in the serum of men with healthy prostates. Crucially, many prostate disorders elevate serum PSA levels, one of which is prostate cancer. Our cover feature draws attention to the big debate over the value of PSA screening for the detection of prostate cancer.

To provide insight into what research has been performed on this topic, a series of metrics were applied to the last five years of the published literature. We asked:

  • What are the major topics for the field?
  • Which publications have the greatest impact?
  • How is the knowledge available online?
  • Who are the most prolific authors?

PubMed, was searched for prostate cancer AND “prostate specific antigen” with results limited to the last five years, in humans (for a clinical focus). The data were analyzed in Microsoft Excel 2013.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Mark Hillen

More Articles by Mark Hillen

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.